BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25201534)

  • 21. Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment.
    Pontes O; Costa M; Santos F; Sampaio-Marques B; Dias T; Ludovico P; Baltazar F; Proença F
    Eur J Med Chem; 2018 Sep; 157():101-114. PubMed ID: 30081238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel AHLs as potent antiproliferative agents.
    Ren JL; Zhang XY; Yu B; Wang XX; Shao KP; Zhu XG; Liu HM
    Eur J Med Chem; 2015 Mar; 93():321-9. PubMed ID: 25707012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
    Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
    Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
    Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest.
    Bortolotto LF; Barbosa FR; Silva G; Bitencourt TA; Beleboni RO; Baek SJ; Marins M; Fachin AL
    Biomed Pharmacother; 2017 Jan; 85():425-433. PubMed ID: 27903423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methoxy- and fluoro-chalcone derivatives arrest cell cycle progression and induce apoptosis in human melanoma cell A375.
    Henmi K; Hiwatashi Y; Hikita E; Toyama N; Hirano T
    Biol Pharm Bull; 2009 Jun; 32(6):1109-13. PubMed ID: 19483325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
    Cabrera M; Simoens M; Falchi G; Lavaggi ML; Piro OE; Castellano EE; Vidal A; Azqueta A; Monge A; de Ceráin AL; Sagrera G; Seoane G; Cerecetto H; González M
    Bioorg Med Chem; 2007 May; 15(10):3356-67. PubMed ID: 17383189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
    Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC
    Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies.
    Marković V; Debeljak N; Stanojković T; Kolundžija B; Sladić D; Vujčić M; Janović B; Tanić N; Perović M; Tešić V; Antić J; Joksović MD
    Eur J Med Chem; 2015 Jan; 89():401-10. PubMed ID: 25462255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and identification of α-cyano bis(indolyl)chalcones as novel anticancer agents.
    Kumar D; Maruthi Kumar N; Tantak MP; Ogura M; Kusaka E; Ito T
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5170-4. PubMed ID: 25442306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
    Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
    Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
    Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
    Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
    Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
    Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
    Ethiraj KR; Aranjani JM; Khan FR
    Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG.
    Anand N; Singh P; Sharma A; Tiwari S; Singh V; Singh DK; Srivastava KK; Singh BN; Tripathi RP
    Bioorg Med Chem; 2012 Sep; 20(17):5150-63. PubMed ID: 22854194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines.
    Sangpheak K; Mueller M; Darai N; Wolschann P; Suwattanasophon C; Ruga R; Chavasiri W; Seetaha S; Choowongkomon K; Kungwan N; Rungnim C; Rungrotmongkol T
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):134-143. PubMed ID: 30394113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
    Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
    Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells.
    Dos Santos MB; Bertholin Anselmo D; de Oliveira JG; Jardim-Perassi BV; Alves Monteiro D; Silva G; Gomes E; Lucia Fachin A; Marins M; de Campos Zuccari DAP; Octavio Regasini L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1093-1099. PubMed ID: 31117836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
    Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
    Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
    Rostom SA; Hassan GS; El-Subbagh HI
    Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.